Promising FDA updates in ovarian cancer
https://www.facingourrisk.org/XRAY/fda-approves-platinum-resistant-treatment
Full article: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-paclitaxel-platinum-resistant-epithelial-ovarian-fallopian-tube-or
This update highlights recent FDA news focused on ovarian cancer, including a new treatment option and two promising investigational drugs that received the FDA’s Breakthrough Therapy designation. These updates may provide more treatment choices for people with ovarian cancer. (posted 3/09/26)
Questions To Ask Your Health Care Provider
- Is my ovarian cancer platinum sensitive or platinum resistant?
- Has my ovarian cancer been tested for PD-L1? Has my ovarian cancer been tested for folate receptor alpha?
- Has my ovarian cancer been tested for other biomarkers? If so, what were the results? If not, is there any benefit to biomarker testing now?
- Is Keytruda a good treatment option for me?
- What side effects should I expect from treatment, and how can I manage them?
- How long might this treatment keep my cancer under control?
- Do I qualify for any clinical trials?
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.